Cargando…
Risk factors for acute exacerbation of interstitial lung disease during chemotherapy for lung cancer: a systematic review and meta-analysis
PURPOSE: The aim of this study was to investigate the risk factors for acute exacerbation (AE) of interstitial lung disease caused by chemotherapy for lung cancer. METHODS: We searched PubMed, Embase, and The Cochrane Library databases from the establishment of each database to April 2023. Eligible...
Autores principales: | Wang, Zhen, Bai, Jiayu, Liu, Yujia, Li, Peng, Jiao, Guangyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598856/ https://www.ncbi.nlm.nih.gov/pubmed/37886172 http://dx.doi.org/10.3389/fonc.2023.1250688 |
Ejemplares similares
-
Risk factors for acute exacerbation of interstitial lung disease following lung cancer resection: a systematic review and meta-analysis
por: Hao, Xiaohu, et al.
Publicado: (2022) -
Acute Exacerbation in Interstitial Lung Disease
por: Leuschner, Gabriela, et al.
Publicado: (2017) -
Acute exacerbation in interstitial lung disease
por: Alhamad, Esam H., et al.
Publicado: (2021) -
The Efficacy and Safety of First-Line Chemotherapy in Patients With Non-small Cell Lung Cancer and Interstitial Lung Disease: A Systematic Review and Meta-Analysis
por: Wang, Yanning, et al.
Publicado: (2020) -
Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy
por: Sekine, Akimasa, et al.
Publicado: (2022)